Researchers have gained more insight into a mechanism that cancer cells may use to survive, thus identifying potential new targets for treatment of the disease. The study led by researchers at the National Cancer Institute (NCI), published on Jan. 7, 2010, in Nature.
Diffuse large B-cell lymphoma (DLBCL) originates in B cells, which are antibody-producing immune [...]
BCL-6 / HSP90 may be a potential target for lymphoma treatment. Physician-scientists from Weill Cornell Medical College have discovered a molecular mechanism that may prove to be a powerful target for the treatment of non-Hodgkin’s lymphoma, a type of cancer that affects lymphocytes, or white blood cells. By exploiting this mechanism, researchers have been able [...]